ERBB2 and breast carcinoma: , high TILs infiltration was associated with improved disease-free and overall survival in triple-negative patients, but shorter overall survival in HR-positive, HER2-negative tumors [11], indicating a crucial need to better profile the TIME status in luminal breast cancer.